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Statement of findings
Mast cell (MC) activation in the rheumatoid lesion provides numerous mediators that
contribute to inflammatory and degradative processes, especially at sites of cartilage
erosion. MC activation in rheumatoid synovial tissue has often been associated with tumour
necrosis factor (TNF)-α and interleukin (IL)-1β production by adjacent cell types. By
contrast, our in situ and in vitro studies have shown that the production of IL-15 was
independent of MC activation, and was not related to TNF-α and IL-1β expression. Primary
cultures of dissociated rheumatoid synovial cells produced all three proinflammatory
cytokines, with production of IL-1β exceeding that of TNF-α, which in turn exceeded that of
IL-15. In vitro cultures of synovial macrophages, synovial fibroblasts and articular
chondrocytes all produced detectable amounts of free IL-15, macrophages being the most
effective.
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DMEM = Dulbecco’s modified Eagles medium; ELISA = enzyme-linked immunosorbent assay; FCS = foetal calf serum; HBSS = Hanks balanced
salt solution; Ig = immunoglobulin; IHC = immunohistochemistry; IL = interleukin; MC = mast cell; RA = rheumatoid arthritis; TBS = Tris buffered
saline; TNF = tumour necrosis factor.
Introduction: Increased numbers of mast cells (MCs) are found
in the synovial tissues and fluids of patients with rheumatoid
arthritis (RA), and at sites of cartilage erosion. MC activation has
been reported for a significant proportion of rheumatoid
specimens. Because the MC contains potent mediators,
including histamine, heparin, proteinases, leukotrienes and
multifunctional cytokines, its potential contributions to the
processes of inflammation and matrix degradation have recently
become evident.
Proinflammatory cytokines are important mediators of inflammation,
immunity, proteolysis, cell recruitment and proliferation. Tumour
necrosis factor (TNF) reportedly plays a pivotal role in the
pathogenesis of RA, especially its ability to regulate interleukin
(IL)-1β expression, this being important for the induction of
prostanoid and matrix metalloproteinase production by synovial
fibroblasts and chondrocytes. IL-15 has been assigned
numerous biological effects and has been implicated as an
important factor in TNF-α expression by monocyte/macrophages.
Some in vitro studies have placed IL-15 upstream from TNF-α in
the cytokine cascade, suggesting an interdependence between
TNF, IL-1 and IL-15 for the promotion of proinflammatory
cytokine expression in the rheumatoid joint.
Aims: To examine the in situ relationships of TNF-α, IL-1β and
IL-15 in relation to MC activation in rheumatoid tissues by use of
immunolocalization techniques; and to compare quantitatively
the proinflammatory cytokine production by specific cell cultures
and rheumatoid synovial explants with and without exposure to a
MC secretagogue.
Materials and methods: Samples of rheumatoid synovial
tissue and cartilage–pannus junction were obtained from
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Introduction
Rheumatoid arthritis (RA) is characterized by chronic
inflammation, cartilage destruction and joint deformity.
Histopathological observations of the ‘rheumatoid lesion’
– a term used to describe cartilage–pannus junctions and
cartilage erosion sites [1] – have identified a number of
cell types, each of which may contribute different media-
tors to the inflammatory and degradative processes; these
usually being microenvironmental in nature [1,2]. Although
macrophages, fibroblastic synoviocytes, lymphocytes and
neutrophils are recognized as important contributors to
RA joint pathology, the mast cell (MC) has generally been
neglected. Increased numbers of MCs are found in the
synovial tissue and fluid of patients with RA [3,4], and
especially at sites of cartilage erosion [5]. MC activation
has been reported in these locations for a significant pro-
portion of rheumatoid specimens [3]. Because the MC
contains a variety of potent mediators, including histamine,
heparin, proteinases, leukotrienes and multifunctional
cytokines [6,7], its potential contributions to the
processes of inflammation and matrix degradation have
recently become evident [2,8].
Proinflammatory cytokines are important mediators of
inflammation, immunity, proteolysis, cell recruitment and
proliferation. Tumour necrosis factor (TNF)-α and TNF-β,
and interleukin (IL)-1α and IL-1β have received much
attention over the past decade [9–11], and both TNF and
IL-1 have been demonstrated in the rheumatoid lesion by
immunohistochemistry [2,12]. TNF reportedly plays a
pivotal role in the pathogenesis of RA [10,11], especially
its ability to regulate IL-1β expression, this being important
for the induction of prostanoid and matrix metallopro-
teinase production by synovial fibroblasts and chondro-
cytes [9,13]. Cellular interactions mediated by TNF and
IL-1, cytokines that are mainly produced by activated
macrophages, have become prominent factors in the
numerous reviews that have proposed a sequence of
Full article
patients (n = 15) with classic late-stage RA. Tissue sections
were immunostained for MC (tryptase) and the proinflammatory
cytokines IL-1, TNF-α and IL-15. Rheumatoid synovial tissue
explants were cultured in Dulbecco’s modified Eagles medium
(DMEM) containing either the MC secretagogue rabbit
antihuman immunoglobulin (Ig)E, or control rabbit IgG. Primary
rheumatoid synovial cell cultures, human articular
chondrocytes, synovial fibroblasts and synovial macrophages
were prepared as described in the full article. Conditioned
culture media from these cultures were collected and assayed
for IL-1β, TNF-α and IL-15 using enzyme-linked immunosorbent
assay methodology.
Results: Immunohistological studies of rheumatoid synovial
tissues have demonstrated local concentrations of MCs in
most specimens of the rheumatoid lesion. Sites of MC
activation were associated with localized oedema, and TNF-α,
IL-1α and IL-1β production by a proportion of mononuclear
inflammatory cells. By contrast, no evidence was found for IL-
15 production in tissue sites containing either intact or
activated MCs, and IL-15 expression, when observed, bore no
relation to tissue sites where TNF-α and IL-1β were evident.
The immunodetection of IL-15 was restricted to microfocal
sites and was not typical of most junctional specimens, but was
associated with a proportion of articular chondrocytes in a
minority of junctional specimens.
MC activation within synovial explant cultures was induced by
the addition of polyclonal antibody to human IgE. MC activation
significantly reduced the levels of TNF-α and IL-1β released
into the medium, this representing approximately 33% of
control values. By contrast, MC activation had little effect on
the levels of IL-15 released into the culture medium, the
average value being very low in relation to the release of TNF-α
and IL-1β. Thus, induced MC activation brings about changes
in the amounts of released tryptase, TNF-α and IL-1β, but not
of IL-15.
Four preparations of primary rheumatoid synovial cell cultures
produced more IL-1β than TNF-α, with only modest values for
IL-15 production, indicating that all three cytokines are
produced and released as free ligands by these cultures. Of
specific cell types that produced IL-15 in vitro, macrophages
produced more than fibroblasts, which in turn produced more
than chondrocytes. This demonstrates that all three cell types
have the potential to produce IL-15 in situ.
Discussion: The biological consequences of MC activation in
vivo are extremely complex, and in all probability relate to the
release of various combinations of soluble and granular factors,
as well as to the expression of appropriate receptors by
neighbouring cells. The subsequent synthesis and release of
cytokines such as TNF-α and IL-1 may well follow at specific
stages after activation, or may be an induced cytokine
response by adjacent macrophagic or fibroblastic cells.
However, because no IL-15 was detectable either in or around
activated or intact MCs, and the induced MC activation explant
study showed no change in IL-15 production, it seems unlikely
that the expression of this cytokine is regulated by MCs. The
immunohistochemistry (IHC) demonstration of IL-15 at sites of
cartilage erosion, and especially by some chondrocytes of
articular cartilage, showed no spatial relationship with either T
cells or neutrophils, and suggests other functional properties in
these locations. The lack of evidence for an in situ association
of IL-15 with TNF and IL-1 does not support a role for IL-15 in a
proinflammatory cytokine ‘cascade’, as proposed by other in
vitro experiments. We believe that sufficient evidence is
available, however, to suggest that MC activation makes a
significant contribution to the pathophysiological processes of
the rheumatoid lesion.
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events leading to cartilage damage in RA [10,11,13]. The
precise factors that induce monocyte/macrophages to
produce TNF and IL-1 remain obscure, however, although
recent studies [14–16] have suggested a role for IL-15.
IL-15 is reportedly expressed by activated monocytes,
epithelial cells and fibroblasts [17]. IL-15 has been
assigned numerous biological effects: it is a potent T-cell
chemokine; it induces proliferation of mitogen-activated T
cells; it contributes to B-cell proliferation and immuno-
globulin (Ig) synthesis; and it enhances neutrophil and
natural killer cell responses [17]. It was recently implicated
as an important factor in TNF-α expression by monocyte/
macrophages. IL-15 together with IL-6 and TNF-α was
shown to induce monocyte TNF-α production, a response
similarly induced by IL-15-stimulated T cells via contact
with monocytes [14–16]. Other studies have placed IL-15
upstream from TNF-α in the cytokine cascade, showing
that IL-15 activation of T cells directly produces TNF-α as
well as amplifying inflammatory responses [15,17]. Such
reports, derived from in vitro cell studies, have suggested
an interdependence between TNF, IL-1 and IL-15, and
between monocyte/macrophages and T cells, for the pro-
motion of proinflammatory cytokine expression in the
rheumatoid joint. The present study examines these possi-
ble relationships in situ, especially in relation to MC activa-
tion, by use of immunolocalization techniques on freshly
fixed rheumatoid tissues, and by a comparative quantita-
tive assessment of proinflammatory cytokine production by
rheumatoid synovial explants and specific cell cultures.
We report here that IL-15 production in situ does not
appear to be related to sites of TNF or IL-1 production, or
with MC activation, and that synovial explants, synovio-
cytes, macrophages and chondrocytes in vitro produce




Samples of rheumatoid synovial tissue and cartilage–
pannus junction were obtained from arthroplasty speci-
mens from patients (n = 15) with classic late-stage
rheumatoid arthritis (RA). Each sample was fixed in
Carnoy’s fixative at 20°C for 1–2 h and embedded in
paraffin wax, and 5 µm sections were cut. Tissue sections
were dewaxed, rehydrated and examined for the presence
of MCs and the proinflammatory cytokines IL-1, TNF-α and
IL-15 using immunohistochemical techniques.
Immunolocalization of mast cells
Tissue sections were dewaxed and pretreated for 30 min
with 10% rabbit serum (vol/vol) in Tris buffered saline
(TBS) at pH 7.6. Mouse monoclonal antibody to human
MC tryptase (Biogenesis, Poole, Dorset, UK) was diluted
1 : 200 and applied to the sections for 2 h at 20°C. After
three 10-min washes in TBS, alkaline phosphatase-conju-
gated rabbit antimouse IgG (Dako Ltd, Cambridge, UK)
diluted 1 : 50 was applied for 1 h at 20°C. After further
washing the alkaline phosphatase was developed using
new fuchsin substrate. Tissue sections were lightly coun-
terstained with Harris’s haematoxylin or Toluidine blue as
previously described [2,3].
Dual immunolocalization of mast cell tryptase and
cytokines IL-1α, IL-1β or TNF-α
Tissue sections were pretreated for 30min with rabbit
serum at 10% (vol/vol) final concentration in TBS. After
draining, the sections were incubated at 20°C for 2h with a
combination of primary antibodies, namely mouse mono-
clonal antitryptase (diluted 1:200) with either a goat poly-
clonal antibody to IL-1α or IL-1β (diluted 1 :50) or goat
polyclonal antibody to TNF-α (diluted 1 :50). Polyclonal anti-
bodies were purchased from R&D Systems (Abingdon, UK).
After three 10 min washes in TBS, secondary antibodies
alkaline phosphatase-conjugated rabbit antimouse and
horseradish peroxidase-conjugated rabbit antigoat (both
from Dako) diluted 1 :50 in TBS were applied together for
1h at 20°C followed by three 10-min washes in TBS. Perox-
idase was developed first using diaminobenzidine (brown
colour) and the sections were washed, followed by develop-
ment of alkaline phosphatase using new fuchsin (red colour)
as described previously [2]. The sections were lightly coun-
terstained in Harris’s haematoxylin to demonstrate nuclei,
dehydrated, mounted in Histomount (Mensura, Wigan, UK)
and photographed using a Zeiss (Oberkochen, Germany)
photomicroscope III and Ektachrome (Rochester, New York,
USA) 160 tungsten film.
Immunolocalization of interleukin-15
IL-15 was immunolocalized using a goat polyclonal anti-
body from R&D Systems.
Tissue sections were pretreated with 10% (vol/vol) rabbit
serum in TBS for 30 min. The primary antibody, diluted
1 :100 in TBS, was applied to the sections and incubated
for 2h at 20°C. After three 10-min washes, biotinylated
rabbit antigoat IgG was applied to the sections for 45min,
followed by a further washing in TBS. Alkaline phosphatase
conjugated avidin–biotin complex was diluted as recom-
mended by the supplier (Dako) and applied to the sections
for 45min at 20°C. After further washing alkaline phos-
phatase was developed using new fuchsin substrate (red).
Consecutive sections of cartilage–pannus junction and
rheumatoid synovium were stained for MC tryptase, IL-15,
TNF-α and IL-1β, respectively.
Control tissue sections
Normal IgG from the same species and in concentrations
similar to those used for the primary antibodies was substi-
tuted for each primary antibody and consistently gave neg-
ative results. In addition, each cytokine antibody was
preabsorbed with its relevant antigen and used in place of
the primary antibody; this also produced negative data and
confirmed specificity.
Explant cultures
Rheumatoid synovial tissue obtained shortly after surgery
was cut into small pieces of approximately 3 mm3 in Hanks
balanced salt solution (HBSS; Gibco, Paisley, Scotland).
Randomized explants (8–10) were placed in each of four
or six preweighed sterile culture dishes. After reweighing
to determine the wet weight of the tissue per dish, 2 ml
Dulbecco’s modified Eagles medium (DMEM, Gibco) con-
taining either the MC secretagogue rabbit antihuman IgE
or control rabbit IgG, each at a final concentration of
150 µg/ml, was added to the cultures in duplicate or tripli-
cate [18]. The dishes were incubated at 37°C in a 5%
CO2/95% air incubator with humidified atmosphere.
Culture medium was removed at 20 h, aliquoted and
stored at –20°C until it was assayed for the cytokines
TNF-α, IL-1β and IL-15.
Preparation of rheumatoid synovial cell cultures
Rheumatoid synovial tissue was washed with HBSS,
chopped into fine pieces and enzymically digested by
incubation with 10 ml DMEM containing 1 mg/ml bacterial
collagenase (Clostridium hystoliticum; Boehringer,
Mannheim, Germany) in a shaking water bath for 3 h at
37°C. The resultant cell suspension was filtered, washed
with DMEM and the pellet of cells was resuspended in
DMEM + 10% (vol/vol) foetal calf serum (FCS), as
described previously [19]. An aliquot of 200 µl dissoci-
ated synovial cells were plated at a density of 2 × 105
cells/well in 12-well culture dishes and incubated at 37°C
with a 5% CO2 incubator. After 48 h the conditioned
medium was harvested, centrifuged to remove nonadher-
ent cells and stored at –20°C until assaying for the
cytokines TNF-α, IL-1β and IL-15.
Synovial macrophage-enriched cultures
Dissociated rheumatoid synovial cells prepared as
described above were plated into 80 cm2 culture flasks
and, after 24 h, the medium containing the nonadherent
cells was removed and discarded. The remaining adherent
cells, mainly fibroblasts and macrophages, were first
washed with HBSS and then harvested by trypsinization.
The cells were resuspended in HBSS containing 2% FCS
using 80 µl buffer per 107 cells. Cells of anti-fibroblast
microbeads 20 µl per 107 (Miltenyi Biotec, Bisley, Surrey,
UK) was added to the cell suspension and the mixture
was incubated at 20°C for 30 min. The cells were washed
in 20 times the volume of the HBSS and centrifuged at
2000 revolutions/min for 10 min. After resuspension in
1 ml HBSS + 2% FCS, the cells were separated using a
MS+ magnetic separation column (Miltenyi Biotec). The
resultant eluant gave cell preparations that were depleted
of fibroblasts and rich in macrophages. The cells were
plated out in DMEM + 10% FCS into 12-well culture
dishes overnight and then transferred to DMEM + 2%
FCS for 48 h. Cultures were shown to contain more than
90% macrophages by immunostaining with CD68
macrophage marker (Dako; data not shown). The medium
was harvested and stored at –20°C until assaying for the
cytokines IL-1β, TNF-α and IL-15 by enzyme-linked
immunosorbent assay (ELISA). The cells were fixed in the
culture wells, stained and counted.
Rheumatoid synovial fibroblasts
Subcultures of adherent synovial fibroblasts were used at
passages two to four. Cells were plated out in DMEM +
10% FCS into 12-well culture dishes and, when confluent,
the medium was replaced with DMEM + 2% FCS for 48 h.
Medium was collected, stored and assayed for cytokines.
Cells were fixed, stained and counted.
Chondrocyte cultures
Macroscopically normal articular cartilage was enzymically
digested as described previously [20]. Chondrocytes
were grown to confluence in 12-well culture dishes in
DMEM + 10% FCS and used as described above for the
synovial macrophage and fibroblast cultures, after which
cells were fixed, stained and counted.
Measurement of cytokines
IL-1β, TNF-α and IL-15 were measured using Quantikine
ELISA kits from R&D Systems, following the manufactur-
er’s instructions. Detection limits of the ELISAs were
< 1 pg/ml, < 4 pg/ml and < 1 pg/ml for IL-1β, TNF-α and
IL-15, respectively.
Results
Immunohistological studies of rheumatoid synovial tissues
have demonstrated local concentrations of MCs in most
specimens of the rheumatoid lesion. Previous studies have
shown evidence of MC activation in situ, as judged by the
release of the MC-specific enzyme tryptase. Figure 1a
shows MC activation with evidence of local oedema, asso-
ciated with sites of TNF-α production by a proportion of
mononuclear inflammatory cells. Figure 1b also shows
dual immunolocalization of MC tryptase together with IL-
1β production by some neighbouring cells. Associations
of IL-1β and sites of MC activation were similarly observed
[2]. Although MCs are reported to have the potential to
express TNF-α and IL-1, only occasionally has TNF-α pro-
duction by MCs been demonstrated in our rheumatoid
specimens.
The association of TNF-α and IL-1α or IL-1β production by
cells in similar locations to activated MCs was a common
observation. By contrast, no evidence was found for IL-15
production in tissue sites containing either intact or acti-
vated MCs. Figures 1c and 1d show consecutive tissue
sections stained for tryptase and IL-15, respectively; the
latter showing negligible staining despite the presence of
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Figure 1
Immunolocalisation of mast cell tryptase, tumour necrosis factor (TNF)-α, interleukin (IL)-1α and IL-15 in the rheumatoid lesion.
(a) Micrograph showing mast cell tryptase (red) with extracellular staining indicative of mast cell (MC) activation associated with localized
oedema (arrow) and TNF-α expression (brown) by a proportion of mononuclear cells. (b) Micrograph showing mast cell tryptase (red), local MC
activation and associated mononuclear cells stained for IL-1α (brown). (c) Low power micrograph showing distribution of mast cells (tryptase,
red) and their degranulation in rheumatoid synovial tissue. (d) Consecutive section to (c) stained for IL-15. Note the absence of IL-15 from MC
activation sites. (e) Micrograph of cartilage–pannus junction showing both extracellular and intracellular staining for IL-15 (red). Note the
microfocal nature of cytokine production by a minority of cells. (f) Micrograph of rheumatoid lesion showing chondrocytic cells stained for IL-15
(red) with little evidence of cytokine production by the overlying pannus tissue (to right of micrograph). Bars: (a) and (b) 35 µm; (c) and
(d) 120 µm; (e) 35 µm; and (f) 45 µm.
numerous MCs, some of which show evidence of degran-
ulation. Indeed, IL-15 expression, when observed, bore no
relation to tissue sites where TNF-α and IL-1β were
evident. The immunodetection of IL-15 was variable
between the different rheumatoid tissue specimens;
whereas some showed prominent staining of synovial
lining cells, especially CD68+ macrophages, other speci-
mens were devoid of IL-15. Figure 1e shows a
cartilage–pannus junction with evidence of extracellular IL-
15 staining at cartilage erosion sites, and with intracellular
staining localized to a few chondrocytic and macrophagic
cells. This distribution of IL-15 was restricted to microfocal
sites; it was not typical of most junctional specimens, but
was not associated with the local expression of TNF-α or
IL-1. Similarly, Figure 1f shows a proportion of articular
chondrocytes at a cartilage–pannus junction stained for
IL-15. Again, such observations were restricted to discrete
sites where only a proportion of the cells were positive for
IL-15. Thus, it appears that the production of IL-15 in
rheumatoid tissues is independent of MC activation, and
the local production of TNF-α and IL-1α and IL-1β.
We recognize that all of these specimens are fixed at one
window in time, but despite the reported interdependence
of these proinflammatory cytokines we have not as yet
observed any colocalization of IL-15 with TNF or IL-1 in
any of the 15 rheumatoid specimens fixed within minutes
of surgical excision. Table 1 is a general summary of the
immunolocalization data, which provides information on
the relative frequencies for cytokine production in speci-
mens of rheumatoid tissues and at the cartilage–pannus
interface. Of special note is that most positive observa-
tions were microfocal in nature, seldom involving large
groups of cells, with a significant proportion of the CD68+
macrophagic cells showing no evidence of cytokine pro-
duction. Such observations suggest that at least in situ
cytokine expression by macrophages and chondrocytes is
subject to regulation, but the induction factors remain
uncertain. These findings have been further examined
using in vitro studies with rheumatoid synovial explants
and monolayer cultures of specific cell types.
MC activation within synovial explant cultures was induced
by the addition of polyclonal antibody to human IgE, this
being an effective MC secretagogue. Its effect was con-
firmed by the elevated values for MC tryptase in the culture
medium, with most cultures showing more than a threefold
increase over controls (Table 2). Because the cellular com-
position of each synovial specimen is known to be variable in
terms of both total cell numbers and specific cell types,
quantitative differences for tryptase and cytokine values
between cultures were to be expected. MC activation signifi-
cantly reduced the levels of TNF-α released into the medium,
this representing approximately 30% of control values for
most explant cultures (average values being 177.2 and
53.2 pg/ml per 100 mg tissue per 20 h for control and anti-
IgE treatments, respectively). Similarly MC activation
reduced the levels of IL-1β released into the medium, this
representing approximately 33% of control values (averaged
values being 50.1 and 16.1 pg/100 mg tissue per 20 h for
control and anti-IgE treatments, respectively). By contrast,
MC activation apparently had little effect on the levels of IL-
15 released into the culture medium, the average value of
less than 1 pg/ml per 100 mg tissue per 20 h being very low
in relation to the release of TNF-α and IL-1β (Table 2). Thus,
the explant data demonstrate that induced MC activation
brings about changes in the amounts of released tryptase,
TNF-α and IL-1-β, but not of IL-15.
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Table 1
Summary of tryptase and cytokine immunolocalization data
Antigen Cartilage–pannus junctions (n = 35) Rheumatoid synovial tissue (n = 26)
MC tryptase Approximately 50% of specimens showed local All specimens contained MCs, but with variable distributions and
accumulations of MCs, most with extracellular enzyme states of activation both between and within individual specimens
indicative of activation/degranulation
TNF-α Approximately 80% of specimens stained; occasional Most specimens showed only intracellular staining; usually 
extracellular staining of cartilage matrix and intracellular macrophages of the synovial lining layer
staining of chondrocytes
IL-1β Approximately 80% of specimens positive; extracellular Commonly observed for a proportion of macrophages, especially 
distribution often reflecting that for TNF-α those in the lining layer
IL-1α Staining limited to about 30% of specimens and Mainly restricted to a minor proportion of macrophages of the 
usually associated with macrophages synovial lining layer
IL-15* Microfocal staining observed for about 30% of Restricted to approximately 40% of specimens; usually 
specimens, usually associated with macrophages, macrophages of the synovial lining and a few fibroblastic cells; 
and especially chondrocytes; no association with TNF seldom associated with TNF+, IL-1+ or tryptase+ cells
or IL-1
*Interleukin (IL)-15 was examined in 9 and 12 different specimens for cartilage–pannus junction and rheumatoid synovial tisue respectively. The
tryptase, tumour necrosis factor (TNF) and IL-1 data are partly adapted from Tetlow and Woolley [2]. MC, mast cell.
It is possible that the measurements of tryptase and
cytokines in the conditioned culture medium do not nec-
essarily reflect total release or production by the tissue
explants, because the accessibility of each protein into
the culture medium will depend to some extent on the rel-
ative interactions and binding properties to the extracellu-
lar matrix, cells and receptors. To overcome this problem
of possible retention of cytokines by the three-dimen-
sional properties of the explant tissue, production of the
three cytokines by primary cultures of dissociated
rheumatoid synovial cells was examined. Table 3 shows
that, for four preparations of primary rheumatoid synovial
cell cultures, variations were observed for the relative
values of the three cytokines. This in all probability
reflects the different compositions of specific cell types
for each preparation. In three of the cultures, however,
the IL-1β values were greater than those for TNF-α, with
only modest values for IL-15 production. This trend is
borne out by the averaged values for each cytokine; IL-1β
production was greater than that of TNF-α, which in turn
was greater than that of IL-15, these being 190, 85 and
14 pg/106 cells per 48 h, respectively (Table 3). It is rec-
ognized that membrane- or surface-bound forms of these
cytokines exist for specific cell types, and these will not
have contributed to the values presented here because
all cells were removed from the conditioned medium
before assay was carried out. Similarly, cytokine receptor
expression by the cell cultures will contribute to some
cytokine depletion of the conditioned medium. Neverthe-
less, these experiments with primary cultures of synovial
cells give some indication that all three cytokines are pro-
duced and released as free ligands, with IL-15 represent-
ing approximately 5% of the three cytokines present in
the medium after 48 h of culture.
Several cell types have been shown to produce IL-15 in
vitro, but few studies have compared production by differ-
ent cell types. Table 4 shows the values for IL-15 produc-
tion and release into the culture medium by synovial
macrophages, synovial fibroblasts and human articular
chondrocytes. The data were obtained from three different
preparations of each cell type, maintained in medium con-
taining 2% FCS supplement, the latter having no
detectable IL-15. In relation to cell numbers the ability of
these cells to produce IL-15 followed the order
macrophages, followed by fibroblasts, followed by chon-
drocytes, thereby demonstrating that all three cell types
have the potential to produce this cytokine in situ.
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Table 3
Cytokine production by primary dissociated synovial cells
Sample no. TNF-α IL-1β IL-15
856 32 135 7
859 140 420 15
851 104 44 9
848 65 160 25
Average values 85.3 ± 23.4 189.8 ± 80.6 14.0 ± 4.04
Values are expressed as pg/ml per 106 cells per 48 h. IL, interleukin;
TNF, tumour necrosis factor.
Table 4
Comparison of interleukin (IL)-15 production by macrophages,
fibroblasts and chondrocytes from rheumatoid tissues
Cell type IL-15 production in vitro
Synovial macrophages 16.3 ± 4.1
Synovial fibroblasts 8.2 ± 4.4
Chondrocytes 3.7 ± 2.0
Values are expressed as means ± standard error of the mean, and are
given as pg/ml per 106 cells per 48 h (n = 3).
Table 2
Effects of mast cell activation on cytokine production by explanted rheumatoid synovial tissue
Tryptase TNF-α IL-β IL-15
Sample Control Anti-IgE Control Anti-IgE Control Anti-IgE Control Anti-IgE
753 11.1 30.4 138 6.4 24.2 4.1 0.31 0.28
764 28.1 181.6 271 204 11.4 20.9 0.55 0.4
770 8.6 46.6 12.8 276 30.3 11.9 0.54 0.54
773 8.9 47.9 103 8.5 19.1 5.8 0.27 0.3
798 32.3 42.1 97.8 34.6 165.3 38 0.52 0.49
Averaged values 17.8 69.7 177.2 53.2 50.1 16.1 0.44 0.40
Values expressed as ng/ml per 100 mg tissue per 20 h for tryptase and as pg/ml per 100 mg tissue for cytokines. For tryptase P = 0.05, for
tumour necrosis factor-α P = 0.02, and for interleukin (IL)-1β P = 0.28, by Student’s T-test. Ig, immunoglobulin.
Discussion
Recent histological studies of rheumatoid synovial tissues
have demonstrated localized accumulations of MCs and
evidence of their activation/degranulation, especially at car-
tilage erosion sites [2,3]. Because MCs contain or express
numerous potent mediators, including histamine, heparin,
proteinases, prostanoids, cytokines and growth factors, it
seems most likely that MC secretion, activation or degranu-
lation in situ will bring about changes in the local environ-
ment, not least the phenotype of neighbouring cells. For
example, histamine induces tissue oedema via its effects
on endothelial cells, activates chondrocytes via H1 and H2
receptors, and stimulates synoviocytes through H1 recep-
tors [21,22]. Heparin interacts with growth factors, con-
tributes to angiogenesis and stimulates IL-1 production by
monocyte/macrophages [23,24]. Tryptase and chymase
are MC-specific proteinases that degrade various matrix
components, and are capable of activating the zymogen
forms of the matrix metalloproteinases, prostromelysin and
procollagenase [25,26]. These MC enzymes are used to
identify two subsets of MCs in human tissues. One subset
contains both tryptase and chymase, and is termed MCTC;
the other contains only tryptase, and is known as MCT.
Both subsets have been demonstrated in rheumatoid syn-
ovial tissues, where they are purported to exert distinct
functions with regard to inflammatory and degradative
processes [27,28]. In addition to proteinase heterogeneity
the MC subsets are reported to have different cytokine pro-
files; whereas MCT preferentially produce IL-4, IL-5 and IL-
6, the MCTC phenotype contains predominantly IL-4 [29].
Indeed, the realization that MCs can express several multi-
functional cytokines (including the proinflammatory media-
tors TNF-α and IL-1β [7,8]) and various profibrotic
cytokines (such as basic fibroblast growth factor and IL-4),
and have the ability to release membrane-bound TGF-α
[28], suggests numerous functional roles for MCs in the
rheumatoid lesion [30].
Our earlier immunohistochemistry (IHC) studies of rheuma-
toid synovial tissue presented evidence for MC activation, as
judged by the extracellular release of tryptase, and its associ-
ation with the microenvironmental expression of TNF-α, IL-
1α, IL-1β, stromelysin and collagenase-1 [2]. These
observations were in accord with previous reports that
soluble MC products stimulated collagenase production by
cultures of synoviocytes and chondrocytes [31], and
induced monocyte/macrophages to increase IL-1 production
[24]. Such studies suggested that MC activation was likely
to bring about increased proinflammatory cytokine and met-
alloproteinase production in situ, but paradoxically in the
present study the induced MC activation of synovial explants
resulted in a significant reduction in TNF-α and IL-1β release
into the culture medium. Explanations for this are currently
unresolved, but may relate to an increase in the expression of
the relevant receptors or to some binding or sequestration of
these ligands by the tissue matrix or released heparin.
The biological consequences of MC activation in vivo are
extremely complex, and in all probability relate to the
release of various combinations of soluble and granular
factors, as well as the expression of appropriate receptors
by neighbouring cells. As yet we have a poor understand-
ing of the hierarchy of the MC mediators released upon
degranulation. Although histamine is released rapidly and
induces tissue oedema, the solubilization and release of
factors from exocytosed granules provides a temporally
regulated supply of specific signals within the localized
domain of the degranulated MC [23]. The subsequent
synthesis and release of specific cytokines may well follow
at specific stages after activation, or, as demonstrated
here by IHC, may be an induced cytokine response by
adjacent macrophagic or fibroblastic cells. It is therefore
possible that the IHC observations presented here reflect
transient changes in cytokine expression, the extracellular
tissue distribution observed for the tryptase protein possi-
bly taking longer to process or remove from the tissue
than the three cytokines. However, because no IL-15 was
detectable either in or around activated or intact MCs, and
the induced MC activation explant study showed no
change in the IL-15 production, it seems unlikely that the
expression of this cytokine is regulated by MCs.
The proinflammatory cytokines IL-1 and TNF-α are reported
to play important roles in cartilage and bone degradation,
with TNF-α occupying a primary position in the cytokine
cascade through its ability to upregulate production of
other cytokines, including IL-1, granulocyte–macrophage
colony-stimulating factor, IL-6, IL-8 and IL-10 [10,11]. TNF-
α expression by monocyte/macrophages has been demon-
strated both in synovial tissue and at the cartilage–pannus
junction [32]. Similarly, IL-1 and its receptor have been
demonstrated at sites of cartilage erosion [12]. Although
monocyte/macrophages are recognized sources of both
TNF-α and IL-1, in many specimens it is only a proportion
of the macrophage numbers that express these cytokines
at the time of surgery and tissue fixation. Similarly with
MCs, although reported to produce TNF and IL-1 only very
few have been shown to do so in rheumatoid synovial
tissue. Such observations indicate that both TNF and IL-1
expression is subject to regulation, but the nature of the
stimulatory agents remains uncertain [10]. Endotoxin,
immunoglobulins, heparin and rheumatoid factors have
been invoked, but more recent studies have shown the
importance of T cells in mediating TNF and IL-1 production
by monocyte/macrophages, especially via cell surface
signals from T cells after their priming with IL-15 [14–16].
Several cell types are capable of producing IL-15. These
include activated monocytes, macrophages, epithelial
cells, fibroblasts [17,33] and endothelial cells [34], and
now chondrocytes as described in the present study.
Other immunohistochemical studies of IL-15 in rheumatoid
synovial tissues have identified CD68+ lining cells [14],
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macrophages, T cells and natural killer cells as positively
stained for IL-15 [35]. One of its many functions is the
recruitment, migration and activation of T cells, subse-
quently contributing to monocyte-derived TNF-α produc-
tion via cell surface contact [17]. IL-15 is also reported to
stimulate monocytes to produce the chemokines IL-8 and
monocyte chemotactic protein-1, which play important
roles in the regulation of leucocyte infiltration during
inflammation [33], a concept also proposed for the cellular
composition of rheumatoid synovial tissue [35].
The present observations are generally in accord with
these reports, at least with regard to IL-15 expression by
some synovial lining cells. However, the demonstration of
IL-15 at sites of cartilage erosion, and especially by some
chondrocytes of articular cartilage, showed no spatial rela-
tionship with T cells or neutrophils, and therefore suggest
other functional properties in these locations. This is sup-
ported to some extent by the lack of evidence for an in situ
association of IL-15 with TNF and IL-1, observations that
do not necessarily support a role for IL-15 in a proinflam-
matory cytokine ‘cascade’, as determined by in vitro exper-
iments [14–16].
The present study has shown that the production of IL-15
by synovial explants and by cells in vitro was rather
modest when compared with that for TNF-α and IL-1β.
Harada et al [36] reported that fibroblast-like synoviocytes
in culture produced large amounts of IL-15 protein and
messenger RNA, this being elevated when stimulated with
IL-1 or TNF. Receptor expression for each of these
cytokines is clearly an important aspect for the under-
standing of these cytokine interactions, and so too is the
realization that some cell types manifest membrane-bound
cytokines. Biologically active IL-15 was detected in a con-
stitutively expressed, membrane-bound form on normal
human monocytes and monocytic cell lines, prompting
Musso et al [37] to speculate that most of the natural bio-
logical effects of IL-15 are exerted by the cell surface-
bound form. Cell membrane-bound forms of IL-1, TNF-α
and IL-10 have also been reported, but it is unclear at
present how these relate to the corresponding free forms
of TNF-α, IL-1β and IL-15 measured in the experiments
described here. It is apparent that the cellular interactions
and proinflammatory cytokine responses that promote the
inflammatory processes of rheumatoid synovial tissue and
joint destruction are far from being resolved. We believe,
however, that sufficient evidence is available to suggest
that MC activation makes a significant contribution to the
pathophysiological processes of the rheumatoid lesion.
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